Kessler Investment Group, LLC Dexcom Inc Transaction History

Kessler Investment Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$110.31 - $140.45 $4.18 Million - $5.33 Million	-37,933 Reduced 99.67%	125 $14,000
Q1 2024 Apr 22, 2024	BUY	$114.22 - $140.1 $111,021 - $136,177	972 Added 2.62%	38,058 $5.28 Million
Q4 2023 Feb 07, 2024	SELL	$75.49 - $124.16 $90,738 - $149,240	-1,202 Reduced 3.14%	37,086 $4.6 Million
Q3 2023 Oct 18, 2023	BUY	$86.06 - $137.93 $103,099 - $165,240	1,198 Added 3.23%	38,288 $3.57 Million
Q2 2023 Jul 24, 2023	BUY	$112.47 - $130.98 $4.17 Million - $4.86 Million	37,090 New	37,090 $4.77 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Kessler Investment Group, LLC with notifications on news.